
NeuroScan AI is an advanced brain-tumor analysis platform that combines Roboflow’s computer-vision capabilities with Google Gemini’s multimodal intelligence to deliver fast, accurate, and accessible medical insights. Users upload an MRI scan, and the system automatically detects tumor presence, type, and regions of concern through a trained Roboflow model. Gemini then interprets these findings, generates detailed explanations, highlights risks, and produces personalized treatment plans based on global medical guidelines. The platform aims to support early detection, assist clinicians, and provide students and researchers with a reliable analysis tool. NeuroScan AI is lightweight, fully cloud-powered, making it simpler to deploy in academic or early-stage healthcare innovation projects.
23 Nov 2025